1 Parkin DM,Bray F,Ferlay J,et al.Estimatingtheworldcancerbur-den:GLOBOCAN2000.IntCancer,2001,94:153-156. 2 Courtois G,GilmoreTD.Mutations in the NF-kappaB signaling pathway:implications for human disease.Oncogene,2006,25:6831-6843. 3 Gilmore TD.NF-kappa B,KBF1,dorsal,and related matters.Cell,1990,62:841-843. 4 Gilmore TD.Introduction to NF-kappaB:players,pathways,perspectives.Oncogene,2006,25:6680-6684. 5 Sclabas GM,Uwagawa T,Schmidt C,et al.Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin.Cancer,2005,103:2485-2490. 6 Kalaitzidis D,Gilmore TD.Transcription factor crosstalk;the estrogen receptor and NF-kappaB.Trends Endocrinol Metab,2005,16:46-52. 7 Karin M,Cao Y,Greten FR,et al .NF- kB in cancer:from innocent by slander to major culprit.Nat Rev Cmcer,2002,2:301-310. 8 Beg AA,Baltimore D.An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.Science,1996,274:782-784. 9 Rodríguez-Berriguete G,Fraile B,Paniagua R,et al.Expression of NF-kB-related proteins and their modulation during TNF-a-provoked apoptosis in prostate cancer celIs. Prostate,2012,72:40-50. 10 Mimeault M,Johansson SL,Batra SK.Pathobiological implications of the expression of EGFR,pAkt,NF-KB and MIC-1 in prostate cancer stem cells and their progenies.PLoS One,2012,7:e31919.
